2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile adhibetur pro media succinata Trelagliptin.

Trogliptin succinatum dipeptidylum peptidase Ⅳ (DPP - ) inhibitor evolvit ab Takeda (Takeda Pharmaceutical Co, Ltd.) in Iaponia.Potest selective et continue inhibere DPP - et moderari gradum sanguinis GLYCOSA.Fusce probationes ostendunt medicamento salutem et efficaciam bonam habere.Semel in hebdomada efficaciter sanguinem GLYCOSA moderari potest et medicamentum obsequium aegrorum emendare.Mense Maio, 2015, medicamentum ab Iaponia PMDA probatum est ut curatio diabete recenseretur.